Sức khỏe · Dự kiến · Tổng hợp 5 nguồn
Korean obesity drug 'Epe'
Monthly cost around 130,000 won
Nói ngắn gọn
Hanmi Pharmaceutical's Korean obesity drug 'Epe' is expected to launch in October.
First-month medication cost is approximately 130,000 won, about half the cost of Mounjaro.
Epe starts at 2mg and increases dosage every two weeks.
Ý chính
| When | On October 14, the pharmaceutical industry learned the supply prices for Epe by dosage. |
|---|---|
| Who | It is 'Epe' (efeprenataride), a Korean GLP-1 obesity treatment drug developed by Hanmi Pharmaceutical. |
| What | First-month medication cost is 129,800 won, maintenance cost from the fourth month is 299,200 won. |
| How | It starts at 2mg and increases stepwise to 4, 6, 8, and 10mg at two-week intervals. |
Với tôi thì sao?
Patients considering obesity treatment now have a more affordable option than existing imported drugs.
Office workers considering weight management treatment can reduce their financial burden.
